FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024890197> ?p ?o ?g. }

• W2024890197 endingPage "1943" @default.
• W2024890197 startingPage "1935" @default.
• W2024890197 abstract "Many kinds of bispecific antibodies recruiting T cells for cancer therapy have been developed. Side-by-side comparison has shown that CD19-/CD3-bispecific antibodies of the diabody, tandem diabody (Tandab) and quadroma format had similar cytotoxic activity, with Tandab being the most active format. Tandab has also been claimed to be superior to single-chain (sc) Fv-based bispecific constructs although data from a side-by-side comparison are not available. In this study, we compared side-by-side MT103 (bscCD19xCD3), a single-chain bispecific antibody of the BiTE class, with a CD19-/CD3-bispecific representative of the Tandab class. Based on literature data, we have constructed, produced and characterized the LL linker version of Tandab, which was reported to be the most active version of Tandab proteins. A dimeric protein of 114kDa was obtained that showed proper bispecific binding to CD3- and CD19-positive cells and could redirect both pre-stimulated and unstimulated human T cells for lysis of human B lymphoma lines Raji, MEC-1 and Nalm-6. Raji cells were lysed at a half-maximal concentration (EC50) of 10 nM Tandab using pre-stimulated T cells, which closely matched the published activity of LL-Tandab with this particular cell line. MT103 had between 700- and 8000-fold higher efficacy than Tandab for redirected lysis of the three human B lymphoma lines. These data demonstrate that under identical experimental conditions, the BiTE format has far superior activity compared to the Tandab format and is also superior to conventional diabody and quadroma formats. The extraordinary potency of the BiTE class and its representative MT103 may translate into improved anti-tumor activity, lower dosing and lower costs of production compared to other bispecific antibody formats." @default.
• W2024890197 created "2016-06-24" @default.
• W2024890197 creator A5008627097 @default.
• W2024890197 creator A5016911524 @default.
• W2024890197 creator A5019027771 @default.
• W2024890197 creator A5026012898 @default.
• W2024890197 creator A5041306331 @default.
• W2024890197 creator A5054887650 @default.
• W2024890197 creator A5058901224 @default.
• W2024890197 creator A5067203103 @default.
• W2024890197 creator A5080867482 @default.
• W2024890197 date "2007-03-01" @default.
• W2024890197 modified "2023-09-30" @default.
• W2024890197 title "CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis" @default.
• W2024890197 cites W1512026049 @default.
• W2024890197 cites W1529239585 @default.
• W2024890197 cites W1538590433 @default.
• W2024890197 cites W1607133602 @default.
• W2024890197 cites W1840766718 @default.
• W2024890197 cites W1964969705 @default.
• W2024890197 cites W1982762974 @default.
• W2024890197 cites W1987240796 @default.
• W2024890197 cites W1993325062 @default.
• W2024890197 cites W1994406227 @default.
• W2024890197 cites W1998281240 @default.
• W2024890197 cites W2003522381 @default.
• W2024890197 cites W2015956932 @default.
• W2024890197 cites W2020634797 @default.
• W2024890197 cites W2021673674 @default.
• W2024890197 cites W2025779348 @default.
• W2024890197 cites W2059410948 @default.
• W2024890197 cites W2072449326 @default.
• W2024890197 cites W2076787465 @default.
• W2024890197 cites W2083494119 @default.
• W2024890197 cites W2086146164 @default.
• W2024890197 cites W2096996532 @default.
• W2024890197 cites W2104187048 @default.
• W2024890197 cites W2115820004 @default.
• W2024890197 cites W2116555417 @default.
• W2024890197 cites W2119654248 @default.
• W2024890197 cites W2135046653 @default.
• W2024890197 cites W2149807648 @default.
• W2024890197 cites W2254120162 @default.
• W2024890197 cites W4244546556 @default.
• W2024890197 doi "https://doi.org/10.1016/j.molimm.2006.09.032" @default.
• W2024890197 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17083975" @default.
• W2024890197 hasPublicationYear "2007" @default.
• W2024890197 type Work @default.
• W2024890197 sameAs 2024890197 @default.
• W2024890197 citedByCount "97" @default.
• W2024890197 countsByYear W20248901972012 @default.
• W2024890197 countsByYear W20248901972013 @default.
• W2024890197 countsByYear W20248901972014 @default.
• W2024890197 countsByYear W20248901972015 @default.
• W2024890197 countsByYear W20248901972016 @default.
• W2024890197 countsByYear W20248901972017 @default.
• W2024890197 countsByYear W20248901972018 @default.
• W2024890197 countsByYear W20248901972019 @default.
• W2024890197 countsByYear W20248901972020 @default.
• W2024890197 countsByYear W20248901972021 @default.
• W2024890197 countsByYear W20248901972022 @default.
• W2024890197 countsByYear W20248901972023 @default.
• W2024890197 crossrefType "journal-article" @default.
• W2024890197 hasAuthorship W2024890197A5008627097 @default.
• W2024890197 hasAuthorship W2024890197A5016911524 @default.
• W2024890197 hasAuthorship W2024890197A5019027771 @default.
• W2024890197 hasAuthorship W2024890197A5026012898 @default.
• W2024890197 hasAuthorship W2024890197A5041306331 @default.
• W2024890197 hasAuthorship W2024890197A5054887650 @default.
• W2024890197 hasAuthorship W2024890197A5058901224 @default.
• W2024890197 hasAuthorship W2024890197A5067203103 @default.
• W2024890197 hasAuthorship W2024890197A5080867482 @default.
• W2024890197 hasConcept C114684123 @default.
• W2024890197 hasConcept C147483822 @default.
• W2024890197 hasConcept C153911025 @default.
• W2024890197 hasConcept C159654299 @default.
• W2024890197 hasConcept C16232356 @default.
• W2024890197 hasConcept C167672396 @default.
• W2024890197 hasConcept C185592680 @default.
• W2024890197 hasConcept C202751555 @default.
• W2024890197 hasConcept C203014093 @default.
• W2024890197 hasConcept C2778957590 @default.
• W2024890197 hasConcept C3020495827 @default.
• W2024890197 hasConcept C542903549 @default.
• W2024890197 hasConcept C55493867 @default.
• W2024890197 hasConcept C57409179 @default.
• W2024890197 hasConcept C86803240 @default.
• W2024890197 hasConceptScore W2024890197C114684123 @default.
• W2024890197 hasConceptScore W2024890197C147483822 @default.
• W2024890197 hasConceptScore W2024890197C153911025 @default.
• W2024890197 hasConceptScore W2024890197C159654299 @default.
• W2024890197 hasConceptScore W2024890197C16232356 @default.
• W2024890197 hasConceptScore W2024890197C167672396 @default.
• W2024890197 hasConceptScore W2024890197C185592680 @default.
• W2024890197 hasConceptScore W2024890197C202751555 @default.
• W2024890197 hasConceptScore W2024890197C203014093 @default.
• W2024890197 hasConceptScore W2024890197C2778957590 @default.
• W2024890197 hasConceptScore W2024890197C3020495827 @default.

• next